Drug Shortage Report for TRISENOX

Last updated on 2018-07-30 History
Report ID 15753
Drug Identification Number 02407833
Brand name TRISENOX
Common or Proper name Arsenic Trioxide for Injection
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) ARSENIC TRIOXIDE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 mg/10mL ampoule
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-09-08
Actual start date 2017-09-08
Estimated end date 2018-07-20
Actual end date 2018-07-24
Shortage status Resolved
Updated date 2018-07-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2017-07-27 French Compare
v14 2017-07-26 French Compare
v13 2017-07-26 English Compare
v12 2017-07-26 French Compare
v11 2017-07-26 English Compare
v10 2017-07-21 French Compare
v9 2017-07-21 French Compare
v8 2017-07-21 French Compare
v7 2017-07-21 English Compare
v6 2017-07-19 French Compare
v5 2017-07-19 English Compare
v4 2017-07-19 English Compare
v3 2017-07-14 English Compare
v2 2017-07-14 French Compare
v1 2017-07-14 English Compare

Showing 21 to 35 of 35